A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes
Clinical trial NCT02148861 · COMPLETED
Trial details
- NCT number
- NCT02148861
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-26
- Primary completion
- 2015-06-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.